<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s12{background-color:#ffffff;text-align:center;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s11{background-color:#ffffff;text-align:center;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s7{border-bottom:1px SOLID #dee2e6;background-color:#ffffff;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s1{background-color:#ffffff;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s14{background-color:#f9f9f9;text-align:center;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s4{background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s5{border-right: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s9{border-bottom:1px SOLID #dee2e6;border-right:1px SOLID #dee2e6;background-color:#d9edf7;text-align:center;font-weight:bold;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s8{border-bottom:1px SOLID #dee2e6;background-color:#ffffff;}.ritz .waffle .s13{background-color:#f9f9f9;text-align:center;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s6{background-color:#ffffff;text-align:left;color:#444444;font-family:'Arial';font-size:12pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s10{border-bottom:1px SOLID #dee2e6;border-right:1px SOLID #dee2e6;background-color:#d9edf7;text-align:center;font-weight:bold;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s3{background-color:#ffffff;text-align:left;font-weight:bold;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s2{background-color:#ffffff;text-align:left;font-weight:bold;color:#444444;font-family:'Arial';font-size:12pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s0{background-color:#ffffff;text-align:left;font-weight:bold;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="591447532C0" style="width:503px;" class="column-headers-background">A</th><th id="591447532C1" style="width:257px;" class="column-headers-background">B</th></tr></thead><tbody><tr style="height: 20px"><th id="591447532R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0" dir="ltr">Biologics in pregnancy (TNF)</td><td></td></tr><tr style="height: 20px"><th id="591447532R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td class="s1"></td><td></td></tr><tr style="height: 20px"><th id="591447532R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td class="s2" dir="ltr"></td><td></td></tr><tr style="height: 20px"><th id="591447532R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td class="s1">Summary<br>Immunosuppressive<br>Up to date vaccines prior to starting<br>No live vaccines while on biologics<br>Screen for latent TB<br>Caution with pre-malignant conditions (ie cervical HPV)<br>Risk of immediate hypersensitivity reactions 3-5%<br>Resume postnatally, though consider with-holding biologic while surgical wound healing postnatally<br>Anti-TNF not teratogenic and safe in pregnancy, flares of disease treated by anti-TNF likely to compromise wellbeing therefore appropriate to give <br>Due to increased transplacental transfer in increasing gestation, there is gestation-specific timing on when to stop a particular anti-TNF<br></td><td></td></tr><tr style="height: 20px"><th id="591447532R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s1"></td><td></td></tr><tr style="height: 20px"><th id="591447532R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td class="s3" dir="ltr">Background</td><td class="s4" dir="ltr">Summary</td></tr><tr style="height: 20px"><th id="591447532R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td class="s1" dir="ltr">Biological agents refer to biological molecules that are used primarily to treat auto-immune conditions</td><td></td></tr><tr style="height: 20px"><th id="591447532R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td class="s1" dir="ltr">They are also sometimes referred to as cytokine modulators</td><td></td></tr><tr style="height: 20px"><th id="591447532R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td class="s1"></td><td></td></tr><tr style="height: 20px"><th id="591447532R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td class="s3" dir="ltr">Starting biologics</td><td></td></tr><tr style="height: 20px"><th id="591447532R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td class="s1" dir="ltr">Aware patients immune system will be suppressed and increasing susceptibility to infection</td><td class="s4" dir="ltr">Immunosuppressive</td></tr><tr style="height: 20px"><th id="591447532R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td class="s1" dir="ltr">Vaccines need to be up to date prior to commencing</td><td class="s4" dir="ltr">Up to date vaccines prior to starting</td></tr><tr style="height: 20px"><th id="591447532R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td class="s1" dir="ltr">Live vaccines contraindicated once on biologics (live vaccines shouldn&#39;t be given if pregnant)</td><td class="s4" dir="ltr">No live vaccines while on biologics</td></tr><tr style="height: 20px"><th id="591447532R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td class="s1" dir="ltr">Should be screened for latent TB infection and treated prior to starting</td><td class="s4" dir="ltr">Screen for latent TB</td></tr><tr style="height: 20px"><th id="591447532R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td class="s1" dir="ltr">Consider biologics may increase risk of some cancers. Use caution in those with past history cancer or premalignant conditions e.g. HPV infection/cervical cancer</td><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:355px;left:-1px">Caution with pre-malignant conditions (ie cervical HPV)</div></td></tr><tr style="height: 20px"><th id="591447532R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td class="s1" dir="ltr">Risk of immediate hypersensitivity reactions 3-5%</td><td class="s5 softmerge"><div class="softmerge-inner" style="width:355px;left:-1px">Risk of immediate hypersensitivity reactions 3-5%</div></td></tr><tr style="height: 20px"><th id="591447532R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td class="s6" dir="ltr">Postnatally - safe from the neonatal perspective, if the patient has a perineal tear or delivered by c-section then it is advisable to withhold biologics for a few days until initial wound healing has occurred to reduce infection risk.</td><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:655px;left:-1px">Resume postnatally, though consider with-holding biologic while surgical wound healing postnatally</div></td></tr><tr style="height: 20px"><th id="591447532R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td class="s3" dir="ltr"></td><td></td></tr><tr style="height: 20px"><th id="591447532R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td class="s3" dir="ltr">Anti-TNF</td><td></td></tr><tr style="height: 20px"><th id="591447532R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td class="s1" dir="ltr">If used in pregnancy the risk of fetal malformations are similar to those of the general population.</td><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:955px;left:-1px">Anti-TNF not teratogenic and safe in pregnancy, flares of disease treated by anti-TNF likely to compromise wellbeing therefore appropriate to give </div></td></tr><tr style="height: 20px"><th id="591447532R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td class="s1" dir="ltr">Growing evidence that safe to use in pregnancy.</td><td></td></tr><tr style="height: 20px"><th id="591447532R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td class="s1" dir="ltr">Flare ups of disease associated with worse maternal and fetal morbidity</td><td></td></tr><tr style="height: 20px"><th id="591447532R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td class="s1" dir="ltr">Concerns that anti-TNF accumulates in the neonate as transplacental transfer increases in later stages of pregnancy and could lead to immunosuppression</td><td></td></tr><tr style="height: 20px"><th id="591447532R23" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">24</div></th><td class="s1" dir="ltr">To avoid neonatal immunosuppression it is recommended anti-TNF drugs are stopped in pregnancy as below:</td><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:855px;left:-1px">Due to increased transplacental transfer in increasing gestation, there is gestation-specific timing on when to stop a particular anti-TNF</div></td></tr><tr style="height: 20px"><th id="591447532R24" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">25</div></th><td class="s7"></td><td class="s8"></td></tr><tr style="height: 20px"><th id="591447532R25" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">26</div></th><td class="s9" dir="ltr">Drug</td><td class="s10" dir="ltr">Advised gestation to stop taking</td></tr><tr style="height: 20px"><th id="591447532R26" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">27</div></th><td class="s11" dir="ltr">Etanercept</td><td class="s12" dir="ltr">Stop prior to third trimester</td></tr><tr style="height: 20px"><th id="591447532R27" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">28</div></th><td class="s13" dir="ltr">Infliximab</td><td class="s14" dir="ltr">Stop at 16 weeks gestation</td></tr><tr style="height: 20px"><th id="591447532R28" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">29</div></th><td class="s11" dir="ltr">Adalimumab</td><td class="s12" dir="ltr">Stop prior to third trimester</td></tr><tr style="height: 20px"><th id="591447532R29" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">30</div></th><td class="s13" dir="ltr">Certolizumab</td><td class="s14" dir="ltr">Safe all trimesters</td></tr></tbody></table></div>